Livforsakringsbolaget Skandia Omsesidigt Sells 3,500 Shares of Aetna Inc (AET)

Livforsakringsbolaget Skandia Omsesidigt trimmed its position in shares of Aetna Inc (NYSE:AET) by 9.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 32,496 shares of the company’s stock after selling 3,500 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Aetna were worth $5,862,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Havens Advisors LLC acquired a new stake in Aetna in the 4th quarter valued at $3,518,000. Schwab Charles Investment Management Inc. boosted its stake in Aetna by 2.6% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 1,235,475 shares of the company’s stock valued at $222,868,000 after buying an additional 30,799 shares in the last quarter. Coastline Trust Co acquired a new stake in Aetna in the 4th quarter valued at $226,000. Koshinski Asset Management Inc. boosted its stake in Aetna by 22.6% in the 4th quarter. Koshinski Asset Management Inc. now owns 10,885 shares of the company’s stock valued at $1,964,000 after buying an additional 2,005 shares in the last quarter. Finally, Creative Planning boosted its stake in Aetna by 9.2% in the fourth quarter. Creative Planning now owns 19,748 shares of the company’s stock worth $3,562,000 after purchasing an additional 1,666 shares in the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Shares of Aetna Inc (NYSE:AET) traded down $1.61 on Friday, hitting $176.39. The stock had a trading volume of 4,044,285 shares, compared to its average volume of 2,730,000. Aetna Inc has a one year low of $120.39 and a one year high of $194.40. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 1.68. The company has a market cap of $57,520.00, a price-to-earnings ratio of 30.68, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60.

Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.18 by $0.07. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The company had revenue of $14.74 billion for the quarter, compared to analyst estimates of $14.79 billion. During the same quarter last year, the company posted $0.08 EPS. The company’s revenue for the quarter was down 6.2% compared to the same quarter last year. equities analysts expect that Aetna Inc will post 10.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Thursday, January 11th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.13%. The ex-dividend date was Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is 34.78%.

Several equities analysts have recently issued reports on AET shares. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $174.00 price target on the stock in a research note on Thursday, October 12th. Jefferies Group upped their price objective on Aetna from $163.00 to $165.00 and gave the company a “hold” rating in a report on Friday, October 13th. BMO Capital Markets started coverage on Aetna in a report on Monday, October 16th. They issued a “market perform” rating and a $175.00 price target for the company. Cantor Fitzgerald restated a “neutral” rating and issued a $175.00 price target on shares of Aetna in a report on Monday, October 23rd. Finally, Citigroup increased their price objective on Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a report on Thursday, November 2nd. Ten research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $185.94.

COPYRIGHT VIOLATION NOTICE: “Livforsakringsbolaget Skandia Omsesidigt Sells 3,500 Shares of Aetna Inc (AET)” was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://ledgergazette.com/2018/02/10/livforsakringsbolaget-skandia-omsesidigt-sells-3500-shares-of-aetna-inc-aet.html.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply